Clinical trial data reveal that dapagliflozin— a sodium-glucose cotransporter 2
Read moreHome »
The COVID-19 pandemic slowed down for the third week in
Read more(HealthDay)—Treatment with a combination of alpelisib and fulvestrant prolongs progression-free
Read moreIn the largest such study so far undertaken, US researchers
Read more